| Name | Title | Contact Details |
|---|
The Avondale Care Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Health Plan of San Joaquin is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Next Breath is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ispace is a private lunar robotic exploration company that is developing micro robotic technology to provide a low cost and frequent transportation service to and on the Moon, conduct lunar surface exploration to map, process and deliver resources to o...